MIAMI, FL, October 2018 – QPS, a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development, today announced the expansion of its U.S.-based Phase I clinical trial capabilities to support the growing needs of...

read more